Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick...more
11/20/2025
/ Appeals ,
Appellate Courts ,
Breach of Contract ,
Constitutional Challenges ,
Contract Disputes ,
Covered Entities ,
Healthcare ,
Motion to Dismiss ,
Pharmaceutical Industry ,
Pharmacies ,
Preliminary Injunctions ,
Prescription Drugs ,
Section 340B ,
State Legislatures ,
Summary Judgment
Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick...more
10/17/2025
/ Amicus Briefs ,
Appeals ,
Constitutional Challenges ,
Covered Entities ,
Manufacturers ,
Pending Litigation ,
Pharmaceutical Industry ,
Pharmacies ,
Preliminary Injunctions ,
Prescription Drugs ,
Section 340B ,
State and Local Government ,
Stays
GLP-1 therapies are transforming obesity and chronic disease treatment, yet navigating their complex regulatory landscape remains critical. From the Food and Drug Administration’s ‘Green List’ to state-specific rules,...more
10/15/2025
/ Advertising ,
Compliance Management Systems ,
Enforcement Actions ,
Food and Drug Administration (FDA) ,
Imports ,
Off-Label Use ,
Pharmaceutical Industry ,
Pharmacy Benefit Manager (PBM) ,
Prescription Drugs ,
Regulatory Requirements ,
State and Local Government ,
Telehealth
The US Food and Drug Administration (FDA) recently issued warning letters to more than 40 compounding pharmacies, demanding that they cease certain advertising practices for a variety of compounded drug products, including...more
Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick...more
10/2/2025
/ Amicus Briefs ,
Appeals ,
Covered Entities ,
Department of Health and Human Services (HHS) ,
Health Care Providers ,
HRSA ,
Insurance Litigation ,
Pending Litigation ,
Pharmacies ,
Preliminary Injunctions ,
Section 340B ,
State and Local Government
Trending in Telehealth highlights monthly state legislative and regulatory developments that impact the healthcare providers, telehealth and digital health companies, pharmacists and technology companies that deliver and...more
9/8/2025
/ Dentists ,
Digital Health ,
Final Rules ,
Medi-Cal ,
Mental Health ,
New Legislation ,
Proposed Legislation ,
Proposed Rules ,
Regulatory Requirements ,
State and Local Government ,
State Legislatures ,
Telehealth ,
Telemedicine ,
Veterinarians
Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick...more
9/4/2025
/ Amicus Briefs ,
Appeals ,
Contract Disputes ,
Drug Pricing ,
Manufacturers ,
Pending Litigation ,
Pharmaceutical Industry ,
Preliminary Injunctions ,
Prescription Drugs ,
Section 340B ,
State and Local Government ,
State Legislatures
This issue of McDermott Will & Schulte’s Healthcare Regulatory Check-Up highlights regulatory activity for July 2025, including the results of the US Department of Justice’s (DOJ) 2025 National Health Care Fraud Takedown, DOJ...more
8/29/2025
/ Centers for Medicare & Medicaid Services (CMS) ,
Department of Health and Human Services (HHS) ,
Department of Justice (DOJ) ,
Enforcement Actions ,
False Claims Act (FCA) ,
HCPCS ,
Healthcare ,
Healthcare Fraud ,
Inpatient Prospective Payment System (IPPS) ,
Kickbacks ,
Long Term Care Facilities ,
Medicare ,
OIG ,
Outpatient Prospective Payment System (OPPS) ,
Pharmaceutical Industry ,
Physician Fee Schedule ,
Popular ,
Proposed Rules ,
Qui Tam ,
Telehealth
Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick...more
8/14/2025
/ Amicus Briefs ,
Appeals ,
Breach of Contract ,
Healthcare ,
HRSA ,
Medicare ,
Motion to Dismiss ,
Pharmacies ,
Preliminary Injunctions ,
Section 340B ,
Summary Judgment
Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick...more
Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick...more
Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick...more
Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick...more
7/9/2025
/ Appeals ,
Contract Disputes ,
Government Agencies ,
Healthcare ,
Healthcare Reform ,
Hospitals ,
Litigation Strategies ,
Manufacturers ,
Pharmaceutical Industry ,
Prescription Drugs ,
Section 340B
On June 20, 2025, the Oregon legislature passed House Bill (HB) 3410, which amends portions of the corporate practice of medicine law, Senate Bill (SB) 951, enacted on June 9, 2025. As we previously reported, SB 951 prohibits...more
Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick...more
On May 7, 2025, the US District Court for the Northern District of Texas upheld the US Food and Drug Administration’s (FDA’s) decision to remove two tirzepatide injection medications from the FDA’s drug shortage list. This...more
6/13/2025
/ Appeals ,
Drug Compounding ,
Enforcement Actions ,
Food and Drug Administration (FDA) ,
Healthcare ,
Healthcare Reform ,
Judicial Authority ,
Pharmaceutical Industry ,
Prescription Drugs ,
Regulatory Agenda ,
Regulatory Reform ,
Regulatory Requirements ,
Supply Shortages
On June 9, 2025, the Oregon legislature enacted Senate Bill (SB) 951, which prohibits certain ownership of and actions related to professional medical entities and aims to modernize Oregon’s corporate practice of medicine...more
6/12/2025
/ Employer Liability Issues ,
Health Care Providers ,
Healthcare ,
Healthcare Workers ,
Legislative Agendas ,
Non-Compete Agreements ,
Oregon ,
Restrictive Covenants ,
State Legislatures ,
Telehealth ,
Telemedicine
Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick...more
6/12/2025
/ Appeals ,
Contract Disputes ,
Government Agencies ,
Healthcare Facilities ,
Hospitals ,
HRSA ,
Manufacturers ,
Pharmaceutical Industry ,
Pharmacies ,
Preliminary Injunctions ,
Prescription Drugs ,
Section 340B ,
State and Local Government
Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick...more
Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick...more
5/28/2025
/ Appeals ,
Contract Disputes ,
Contract Terms ,
Drug Pricing ,
Healthcare ,
Healthcare Facilities ,
Hospitals ,
Litigation Strategies ,
Manufacturers ,
Pharmacies ,
Prescription Drugs ,
Section 340B ,
State and Local Government
Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick...more
5/22/2025
/ Appeals ,
Contract Disputes ,
Covered Entities ,
Drug Pricing ,
Government Agencies ,
Healthcare ,
Healthcare Facilities ,
Hospitals ,
Litigation Strategies ,
Manufacturers ,
Pharmaceutical Industry ,
Pharmacies ,
Preliminary Injunctions ,
Section 340B ,
State and Local Government
Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick...more
Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick...more
Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick...more
Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick...more
4/17/2025
/ Appeals ,
Healthcare ,
Hospitals ,
HRSA ,
Litigation Strategies ,
Manufacturers ,
Pharmaceutical Industry ,
Pharmacies ,
Prescription Drugs ,
Section 340B ,
State and Local Government